| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| December 10th, 2009 | 23 | Yes |
Popular Name: LY294002 LY294002
Find On: PubMed — Wikipedia — Google
CAS Numbers: 154447-36-6 , 934389-88-5 , [154447-36-6]
154447-36-6; 2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; C15195; LY 294002
2-(4-Morpholinyl)-8-Phenyl-4h-1-Benzopyran-4-One
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; LY 294002
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 0.05 | 6.42 | -28.01 | 1 | 4 | 1 | 46 | 308.357 | 1 | ↓ |
| Hi High (pH 8-9.5) | 1.71 | 5.27 | -99.28 | 7 | 7 | 2 | 113 | 408.481 | 4 | ↓ |
| Mid Mid (pH 6-8) | 3.64 | 8.22 | -10.99 | 0 | 4 | 0 | 43 | 307.349 | 2 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| ALOGPS_SOLUBILITY | 1.27e-01 g/l | DrugBank-experimental |
| MP | 240 - 241 °C | Fluorochem |
| Purity | >98% | Fluorochem |
| UniProt Database Links | CDN1B_CANFA; CDN1B_CRIGR; CDN1B_FELCA; CDN1B_HUMAN; CDN1B_MOUSE; ENPP3_HUMAN; NHE1_DICDI; P3C2A_HUMAN; P3C2A_MOUSE; P3C2A_PONAB; RUFY3_RAT; SMG1_HUMAN; SMG1_MOUSE | ChEBI |
| Target | PI3K | Selleck Chemicals |
| Reactome Database Links | REACT_147854 | ChEBI |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| GSK3B-7-E | Glycogen Synthase Kinase-3 Beta (cluster #7 Of 7), Eukaryotic | Eukaryotes | 8100 | 0.31 | Binding ≤ 10μM |
| MTOR-1-E | Serine/threonine-protein Kinase MTOR (cluster #1 Of 3), Eukaryotic | Eukaryotes | 5000 | 0.32 | Binding ≤ 10μM |
| P3C2B-1-E | Phosphatidylinositol-4-phosphate 3-kinase C2 Domain-containing Beta Polypeptide (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2100 | 0.35 | Binding ≤ 10μM |
| P85A-2-E | PI3-kinase P85-alpha Subunit (cluster #2 Of 2), Eukaryotic | Eukaryotes | 1400 | 0.36 | Binding ≤ 10μM |
| PIM1-1-E | Serine/threonine-protein Kinase PIM1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 820 | 0.37 | Binding ≤ 10μM |
| PIM3-1-E | Serine/threonine-protein Kinase PIM3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1400 | 0.36 | Binding ≤ 10μM |
| PK3CA-2-E | PI3-kinase P110-alpha Subunit (cluster #2 Of 2), Eukaryotic | Eukaryotes | 500 | 0.38 | Binding ≤ 10μM |
| PK3CB-1-E | PI3-kinase P110-beta Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 900 | 0.37 | Binding ≤ 10μM |
| PK3CD-1-E | PI3-kinase P110-delta Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 500 | 0.38 | Binding ≤ 10μM |
| PK3CG-1-E | PI3-kinase P110-gamma Subunit (cluster #1 Of 3), Eukaryotic | Eukaryotes | 7260 | 0.31 | Binding ≤ 10μM |
| PLK1-1-E | Serine/threonine-protein Kinase PLK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2100 | 0.35 | Binding ≤ 10μM |
| PLK3-1-E | Serine/threonine-protein Kinase PLK3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3000 | 0.34 | Binding ≤ 10μM |
| PRKDC-1-E | DNA-dependent Protein Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6000 | 0.32 | Binding ≤ 10μM |
| Z103203-1-O | A375 (cluster #1 Of 3), Other | Other | 8400 | 0.31 | Functional ≤ 10μM |
| Z80156-12-O | HL-60 (Promyeloblast Leukemia Cells) (cluster #12 Of 12), Other | Other | 9940 | 0.30 | Functional ≤ 10μM |
| Z80418-2-O | RAW264.7 (Monocytic-macrophage Leukemia Cells) (cluster #2 Of 9), Other | Other | 10000 | 0.30 | Functional ≤ 10μM |
| Z80548-3-O | THP-1 (Acute Monocytic Leukemia Cells) (cluster #3 Of 5), Other | Other | 1650 | 0.35 | Functional ≤ 10μM |
| Z80682-1-O | A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other | Other | 8400 | 0.31 | Functional ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| PK3CA_MOUSE | P42337 | PI3-kinase P110-alpha Subunit, Mouse | 500 | 0.38 | Binding ≤ 1μM |
| PK3CA_HUMAN | P42336 | PI3-kinase P110-alpha Subunit, Human | 200 | 0.41 | Binding ≤ 1μM |
| PK3CA_BOVIN | P32871 | PI3-kinase P110-alpha Subunit, Bovin | 630 | 0.38 | Binding ≤ 1μM |
| PK3CB_HUMAN | P42338 | PI3-kinase P110-beta Subunit, Human | 306 | 0.40 | Binding ≤ 1μM |
| PK3CD_HUMAN | O00329 | PI3-kinase P110-delta Subunit, Human | 500 | 0.38 | Binding ≤ 1μM |
| PIM1_HUMAN | P11309 | Serine/threonine-protein Kinase PIM1, Human | 820 | 0.37 | Binding ≤ 1μM |
| PRKDC_HUMAN | P78527 | DNA-dependent Protein Kinase, Human | 1200 | 0.36 | Binding ≤ 10μM |
| MTOR_HUMAN | P42345 | FK506 Binding Protein 12, Human | 2500 | 0.34 | Binding ≤ 10μM |
| GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 8100 | 0.31 | Binding ≤ 10μM |
| P3C2B_HUMAN | O00750 | Phosphatidylinositol-4-phosphate 3-kinase C2 Domain-containing Beta Polypeptide, Human | 2100 | 0.35 | Binding ≤ 10μM |
| PK3CA_MOUSE | P42337 | PI3-kinase P110-alpha Subunit, Mouse | 500 | 0.38 | Binding ≤ 10μM |
| PK3CA_HUMAN | P42336 | PI3-kinase P110-alpha Subunit, Human | 1400 | 0.36 | Binding ≤ 10μM |
| PK3CA_BOVIN | P32871 | PI3-kinase P110-alpha Subunit, Bovin | 10000 | 0.30 | Binding ≤ 10μM |
| PK3CB_HUMAN | P42338 | PI3-kinase P110-beta Subunit, Human | 1400 | 0.36 | Binding ≤ 10μM |
| PK3CD_HUMAN | O00329 | PI3-kinase P110-delta Subunit, Human | 1330 | 0.36 | Binding ≤ 10μM |
| PK3CG_HUMAN | P48736 | PI3-kinase P110-gamma Subunit, Human | 1200 | 0.36 | Binding ≤ 10μM |
| P85A_HUMAN | P27986 | PI3-kinase P85-alpha Subunit, Human | 1400 | 0.36 | Binding ≤ 10μM |
| PIM1_HUMAN | P11309 | Serine/threonine-protein Kinase PIM1, Human | 4000 | 0.33 | Binding ≤ 10μM |
| PIM3_HUMAN | Q86V86 | Serine/threonine-protein Kinase PIM3, Human | 1400 | 0.36 | Binding ≤ 10μM |
| PLK1_HUMAN | P53350 | Serine/threonine-protein Kinase PLK1, Human | 2000 | 0.35 | Binding ≤ 10μM |
| PLK3_HUMAN | Q9H4B4 | Serine/threonine-protein Kinase PLK3, Human | 3000 | 0.34 | Binding ≤ 10μM |
| Z103203 | Z103203 | A375 | 8400 | 0.31 | Functional ≤ 10μM |
| Z80682 | Z80682 | A549 (Lung Carcinoma Cells) | 8400 | 0.31 | Functional ≤ 10μM |
| Z80156 | Z80156 | HL-60 (Promyeloblast Leukemia Cells) | 9940 | 0.30 | Functional ≤ 10μM |
| Z80418 | Z80418 | RAW264.7 (Monocytic-macrophage Leukemia Cells) | 10000 | 0.30 | Functional ≤ 10μM |
| Z80548 | Z80548 | THP-1 (Acute Monocytic Leukemia Cells) | 1010 | 0.36 | Functional ≤ 10μM |
| Description | Species |
|---|---|
| Constitutive PI3K/AKT Signaling in Cancer |
| Description | Species |
|---|---|
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | |
| AKT phosphorylates targets in the cytosol | |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messenge | |
| APC truncation mutants have impaired AXIN binding | |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins | |
| AXIN missense mutants destabilize the destruction complex | |
| Beta-catenin phosphorylation cascade | |
| CD28 dependent PI3K/Akt signaling | |
| Condensation of Prophase Chromosomes | |
| Constitutive PI3K/AKT Signaling in Cancer | |
| Costimulation by the CD28 family | |
| CRMPs in Sema3A signaling | |
| Cyclin A/B1 associated events during G2/M transition | |
| Cytosolic sensors of pathogen-associated DNA | |
| DAP12 signaling | |
| Degradation of beta-catenin by the destruction complex | |
| disassembly of the destruction complex and recruitment of AXIN to the membrane | |
| Downstream signal transduction | |
| Downstream TCR signaling | |
| G alpha (12/13) signalling events | |
| G alpha (q) signalling events | |
| G beta:gamma signalling through PI3Kgamma | |
| GAB1 signalosome | |
| Golgi Cisternae Pericentriolar Stack Reorganization | |
| GP1b-IX-V activation signalling | |
| GPVI-mediated activation cascade | |
| HSF1-dependent transactivation | |
| Interleukin receptor SHC signaling | |
| Interleukin-3, 5 and GM-CSF signaling | |
| Interleukin-7 signaling | |
| IRF3-mediated induction of type I IFN | |
| Loss of Nlp from mitotic centrosomes | |
| Loss of proteins required for interphase microtubule organization from the ce | |
| misspliced GSK3beta mutants stabilize beta-catenin | |
| Mitotic Metaphase/Anaphase Transition | |
| Mitotic Prometaphase | |
| Mitotic Telophase/Cytokinesis | |
| mTOR signalling | |
| Nephrin interactions | |
| Nonhomologous End-joining (NHEJ) | |
| Phosphorylation of Emi1 | |
| Phosphorylation of the APC/C | |
| PI-3K cascade | |
| PI3K Cascade | |
| PI3K events in ERBB2 signaling | |
| PI3K events in ERBB4 signaling | |
| PI3K/AKT activation | |
| PIP3 activates AKT signaling | |
| Polo-like kinase mediated events | |
| Processing of DNA ends prior to end rejoining | |
| Recruitment of mitotic centrosome proteins and complexes | |
| Regulation of HSF1-mediated heat shock response | |
| Regulation of PLK1 Activity at G2/M Transition | |
| Regulation of signaling by CBL | |
| Release of eIF4E | |
| Resolution of Sister Chromatid Cohesion | |
| Role of LAT2/NTAL/LAB on calcium mobilization | |
| Role of phospholipids in phagocytosis | |
| S33 mutants of beta-catenin aren't phosphorylated | |
| S37 mutants of beta-catenin aren't phosphorylated | |
| S45 mutants of beta-catenin aren't phosphorylated | |
| S6K1-mediated signalling | |
| Separation of Sister Chromatids | |
| Signaling by constitutively active EGFR | |
| Signaling by FGFR mutants | |
| Signaling by FGFR1 fusion mutants | |
| Signaling by SCF-KIT | |
| Synthesis of PIPs at the plasma membrane | |
| T41 mutants of beta-catenin aren't phosphorylated | |
| Tie2 Signaling | |
| truncations of AMER1 destabilize the destruction complex | |
| VEGFA-VEGFR2 Pathway | |
| VEGFR2 mediated vascular permeability |
No pre-computed analogs available. Try a structural similarity search.